Skip to main content
. 2022 Jun 22;8(1):e10356. doi: 10.1002/btm2.10356

TABLE 2.

Summary of molecular diagnostic tests for SARS‐CoV‐2 (EUAs)

Detection target Collected samples Limit of detection (LoD) Manufacturer Detection principle Diagnostic Source
ORF1ab, E gene individual or pooled nasal, nasopharyngeal, and oropharyngeal swab samples

Target 1 (SARS‐CoV‐2): 25 copies/ml (95% CI: 17–58 copies/ml)

Target 2 (pan‐Sarbecovirus): 32 copies/ml (95% CI: 21–73 copies/ml)

Roche Molecular Systems, Inc. (RMS) Real‐time RT‐PCR Cobas SARS‐CoV‐2 126
ORF1ab and N gene upper respiratory tract specimens 1 copy/μl SEASUN BIOMATERIALS, Inc. RT‐LAMP AQ‐TOP COVID‐19 Rapid Detection Kit PLUS 127
upper respiratory and BAL specimens 150 copies/ml Euroimmun US, Inc. Real‐time RT‐PCR EURORealTime SARS‐Cov‐2 128
N gene, RNase P gene nasopharyngeal, anterior nasal, mid‐turbinate, oropharyngeal swab specimens, nasopharyngeal wash/aspirate, and nasal aspirate specimens

640 GC/ml (Determination of SARS‐CoV‐2 heat‐inactivated virus)

40 GE/ml (Detection of quantified genomic viral RNA from SARS‐CoV‐2)

Becton, Dickinson and Company (BD) Real‐time RT‐PCR BD SARS‐CoV‐2 Reagents for BD MAX System 129
nasopharyngeal swab, oropharyngeal swab, mid‐turbinate nasal swab, and anterior nasal swab specimens 0.125 copies/μl Fluidigm Corporation Real‐time RT‐PCR Advanta Dx COVID‐19 EASE assay 130
upper respiratory specimens 20 copies/μl Mammoth Biosciences, Inc. RT‐LAMP, CRISPR/Cas12 SARS‐CoV‐2 DETECTR Reagent Kit 131
anterior nares specimens 250 copies/swab LGC, Biosearch Technologies End‐Point RT‐PCR Biosearch Technologies SARS‐CoV‐2 ultra‐high‐throughput End‐Point RT‐PCR Test 132
upper respiratory specimens 1.2 copies/μl Exact Sciences Laboratories Real‐time RT‐PCR SARS‐CoV‐2 (N gene detection) Test 133
anterior nasal swab specimens 6.25 copies/μl Premier Medical Laboratory Services Real‐time RT‐PCR PMLS SARS‐CoV‐2 Assay 134
nasopharyngeal and oropharyngeal swab specimens 1 copy/μl Avellino Lab USA, Inc. Real‐time RT‐PCR AvellinoCoV2 test 135
OFR1ab, N gene, RNase P gene nasopharyngeal swabs, and anterior or mid‐turbinate nasal swabs

Nasopharyngeal swab: 75 GCE/ml of sample

Anterior nasal swab: 75 GCE/ml of sample

Thermo Fisher Scientific Inc. Real‐time RT‐PCR TaqPath COVID‐19 RNase P Combo Kit 2.0 136
upper respiratory tract specimens and bronchoalveolar lavage specimens

ORF1ab target: 6.75 cp/μl VTM

N target: 1.35 cp/μl VTM

Sherlock BioSciences, Inc. Sherlock,RT‐LAMP, CRISPR Sherlock CRISPR SARS‐CoV‐2 Kit 137
N and E gene nasopharyngeal (NP), oropharyngeal (OP), mid‐turbinate (MT), and anterior nares (nasal) swabs 75 copies/μl MobileDetect Bio Inc. RT‐LAMP MobileDetect Bio BCC19 (MD‐Bio BCC19) Test Kit 138
upper respiratory specimens 0.0200 PFU/ml Cepheid Real‐time RT‐PCR Xpert Xpress SARS‐CoV‐2 test 139
saliva specimens 6400 GE/ml MicroGEM U.S., Inc. Real‐time RT‐PCR MicroGEM Sal6830 SARS‐CoV‐2 Saliva Test 140
N gene upper respiratory tract specimens 20 copies/μl UCSF Health Clinical Laboratories, UCSF Clinical Labs at China Basin RT‐LAMP, CRISPR/Cas12 SARS‐CoV‐2 RNA DETECTR Assay 141
nasopharyngeal, anterior nasal, mid‐turbinate nasal, or oropharyngeal swab specimens 100 copies/ml (nasopharyngeal matrix) Mammoth Biosciences, Inc RT‐LAMP, CRISPR DETECTR BOOST SARS‐CoV‐2 Reagent Kit 142
ORF1ab anterior nasal swab samples 800 copies/ml Detect, Inc. LAMP, Lateral Flow Strips Detect Covid‐19 Test 143
RdRP, E, and N genes nasopharyngeal (NP), oropharyngeal (OP), bronchoalveolar lavage (BAL) specimens 140 copies/ml PlexBio Co., Ltd. RT‐PCR IntelliPlex SARS‐CoV‐2 Detection Kit 144
N, ORF1ab, S gene, RNase P RNA (and DNA) anterior nasal swab specimens 1 copy/μl UCSD BCG EXCITE Lab Real‐time RT‐PCR UCSD EXCITE COVID‐19 EL Test 145